 REDUCER I Study Shows Improvement in Chest Pain SymptomsVancouver, British Columbia and Minneapolis, Minnesota--Newsfile Corp. - December 17, 2020 - Neovasc Inc. NASDAQ: NVCN TSX: NVCN Neovasc or the Company announced today that EuroIntervention, the official journal of EuroPCR and the European Association of Percutaneous Coronary Interventions EAPCI, has published online a peer-reviewed study announcing the outcomes of patients undergoing Neovasc ReducerTM Reducer implantation in the Companys REDUCER-I trial. The article, entitled Coronary Sinus Narrowing for the Treatment of Refractory Angina A Multi-center... 